Ozempic, a type 2 diabetes drug that has increasingly been used to help with weight loss, will now be labeled as having the potential to block intestines.
Sep 28, 2023
0
5
New research presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD), Hamburg (2–6 Oct), shows that treatment with the drug semaglutide significantly improves blood sugar control and ...
Oct 2, 2023
0
21
Over 40 percent of Canadians have used at least one risk-associated alternative health-care treatment in the past 12 months, says a new UBC study published in PLOS One.
Sep 28, 2023
0
35
A top UVA Health cancer expert is highlighting how a new drug could transform how doctors treat a brain tumor that typically strikes younger people.
Sep 29, 2023
0
3
Researchers at ETH Zurich have developed a suction cup that allows medications to be absorbed through the mucosal lining of the cheeks. This new approach could spare millions of patients the pain and fear associated with ...
Sep 27, 2023
0
13
MDMA, commonly known as ecstasy, is a recreational psychedelic drug often used at parties and dance clubs because it creates feelings of closeness and social connection with others. Because of this "empathogenic" effect, ...
Oct 2, 2023
0
23
A fast-acting medication delivered as a nasal spray may someday allow patients with intermittent rapid heartbeats to treat it themselves as soon as they develop symptoms, according to new research published today in the Journal ...
Sep 27, 2023
0
52
Tezepelumab is associated with a reduction in occlusive mucus plugs versus placebo in adults with uncontrolled asthma, according to a study published in the October issue of NEJM Evidence.
Sep 29, 2023
0
1
In eastern Africa, malaria parasites have developed resistance to artemisinins, the backbone of current treatment regimens, a development that could dramatically worsen malaria's impact if partner drugs fail in the future.
Sep 27, 2023
0
35
New Cleveland Clinic-led research shows commonly used COVID-19 anti-viral drugs Paxlovid (nirmatrelvir) and Lagevrio (molnupiravir) reduce risk of hospitalization and death in high-risk patients with mild disease, even with ...
Sep 28, 2023
0
19
